KRAS Wild-type patients (n = 66) | Â | Â | Â | Â | |||
---|---|---|---|---|---|---|---|
Factor | Cut-off | No. of pts | Median times (months) | Univariate analysis | Multivariate analysis | ||
 |  |  |  | HR (95%CI) | p-valule | HR(95%CI) | p-value |
EREG | Low | 34 | 74.1 | 1.00 | 0.021* | 1.00 | 0.006* |
 | High | 30 | 42.1 | 2.80 |  | 3.73 |  |
 |  |  |  | (1.17-7.03) |  | (1.46-10.10) |  |
pN | Negative | 15 | not reached | 1.00 | 0.022* | 1.00 | 0.014* |
 | Positive | 49 | 47.6 | 3.28 |  | 3.66 |  |
 |  |  |  | (1.17-11.74) |  | (1.28-13.34) |  |
Depth | T1,2 | 8 | not reached | 1.00 | 0.398 | 1.00 | 0.111 |
 | T3,4 | 56 | 56.6 | 1.78 |  | 2.98 |  |
 |  |  |  | (0.52-11.16) |  | (0.80-19.41) |  |
KRAS mutant patients (n = 43) | Â | Â | Â | Â | |||
Factor | Cut-off | No. of pts | Median times (months) | Univariate analysis | Multivariate analysis | ||
 |  |  |  | HR (95%CI) | p-valule | HR(95%CI) | p-value |
EREG | Low | 22 | 37.1 | 1.00 | 0.048* | 1.00 | 0.090 |
 | High | 21 | 58.1 | 0.37 |  | 0.42 |  |
 |  |  |  | (0.13-0.99) |  | (0.14-1.14) |  |
pN | Negative | 17 | not reached | 1.00 | 0.182 | 1.00 | 0.383 |
 | Positive | 26 | 41.4 | 1.98 |  | 1.58 |  |
 |  |  |  | (0.73-6.25) |  | (0.58-5.03) |  |
Depth | T1,2 | 6 | not reached | 1.00 | 0.178 | 1.00 | 0.301 |
 | T3,4 | 37 | 37.1 | 3.21 |  | 2.55 |  |
 |  |  |  | (0.65-58.11) |  | (0.51-46.40) |  |